Title:
【発明の名称】キノキサリンジオン類
Document Type and Number:
Japanese Patent JP2000509730
Kind Code:
A
Abstract:
The present invention provides a substantially pure compound of formula (I), or a pharmaceutically acceptable salt or solvate thereof, together with compositions containing, uses of, processes for the preparation of and intermediates used in the preparation of such compounds.
More Like This:
| WO/2016/030443 | GLYCOSIDASE INHIBITORS |
| JP5242691 | 1,1,1-Trifluoro-2-hydroxy-3-phenylpropane derivative |
| WO/2016/187046 | SURVIVIN-TARGETING ANTI-TUMOR AGENTS AND USES THEREOF |
Inventors:
Stove, Alan
Gottier, Elizabeth Colette Louise
Weight, david charles
Crook, Robert James
Gottier, Elizabeth Colette Louise
Weight, david charles
Crook, Robert James
Application Number:
JP53732798A
Publication Date:
August 02, 2000
Filing Date:
February 24, 1998
Export Citation:
Assignee:
Pfizer Inc.
International Classes:
A61K31/498; A61P9/10; A61P25/00; A61P25/02; A61P25/06; A61P25/10; A61P25/16; A61P25/28; A61P25/30; A61P27/16; A61P43/00; C07D401/14; (IPC1-7): C07D401/14; A61K31/498; A61P25/00; A61P25/28; A61P43/00
Attorney, Agent or Firm:
Kazuo Shamoto (5 outside)